Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus
- PMID: 20645875
- PMCID: PMC2963630
- DOI: 10.1089/jir.2010.0060
Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus
Abstract
Approximately 500 million people worldwide are chronically infected with the hepatitis B virus (HBV) or hepatitis C virus (HCV), and are therefore at an increased risk for developing fatal liver diseases such as cirrhosis and hepatocellular carcinoma. The intracellular antiviral responses induced by interferon (IFN)-alpha/-beta and/or IFN-gamma play critical roles in the pathogenesis of HBV and HCV infection, and the function of IFN-lambda in the host immune response to these viruses is beginning to be revealed. A better understanding of how IFN-lambda influences HBV or HCV persistence is not only important for understanding the mechanisms of chronic virus infection, but also may lead to new approaches for improved antiviral therapies.
Figures
References
-
- Asnis GM. De La Garza R., 2nd Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol. 2006;40(4):322–335. - PubMed
-
- Coccia EM. Severa M. Giacomini E. Monneron D. Remoli ME. Julkunen I. Cella M. Lande R. Uze G. Viral infection and toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol. 2004;34(3):796–805. - PubMed
-
- Conjeevaram HS. Fried MW. Jeffers LJ. Terrault NA. Wiley-Lucas TE. Afdhal N. Brown RS. Belle SH. Hoofnagle JH. Kleiner DE. Howell CD. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology. 2006;131(2):470–477. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
